Oncolytic poxvirus armed with Fas ligand leads to induction of cellular Fas receptor and selective viral replication in FasR-negative cancer.
about
From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancerThe evolution of poxvirus vaccinesEnhancing the bystander killing effect of an oncolytic HSV by arming it with a secretable apoptosis activator.A rationally designed A34R mutant oncolytic poxvirus: improved efficacy in peritoneal carcinomatosis.Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer.
P2860
Oncolytic poxvirus armed with Fas ligand leads to induction of cellular Fas receptor and selective viral replication in FasR-negative cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Oncolytic poxvirus armed with ...... ation in FasR-negative cancer.
@ast
Oncolytic poxvirus armed with ...... ation in FasR-negative cancer.
@en
type
label
Oncolytic poxvirus armed with ...... ation in FasR-negative cancer.
@ast
Oncolytic poxvirus armed with ...... ation in FasR-negative cancer.
@en
prefLabel
Oncolytic poxvirus armed with ...... ation in FasR-negative cancer.
@ast
Oncolytic poxvirus armed with ...... ation in FasR-negative cancer.
@en
P2093
P2860
P356
P1433
P1476
Oncolytic poxvirus armed with ...... ation in FasR-negative cancer.
@en
P2093
D L Bartlett
M A Kavanagh
M E O'Malley
M Sathaiah
P Thirunavukkarasu
R Ravindranathan
P2860
P2888
P304
P356
10.1038/CGT.2011.77
P577
2011-11-25T00:00:00Z